1. Volume 56, Issue 3, Pages 495-503 (September 2009)
Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo- controlled Phase III Multicentre Study 
Andreas Böhle, Herbert Leyh, Christian Frei, Michael Kühn, Reinhold Tschada, Tobias Pottek, Walter Wagner, Helmut H. Knispel, Wolfgang von Pokrzywnitzki, Ferruh Zorlu, Karin Helsberg, Birgit Lübben, Victoria Soldatenkova, Clemens Stoffregen, Hartwig Büttner 
European Urology 
Volume 56, Issue 3, Pages (September 2009)
DOI: /j.eururo
Copyright © 2009 European Association of Urology Terms and Conditions

2. Fig. 1 Patient disposition.
GEM=gemcitabine; PBO=placebo; CIS=carcinoma in situ.
a Includes discontinuations because of clinical recurrence without histopathologic confirmation (GEM: one patient; PBO: two patients).
European Urology  , DOI: ( /j.eururo )
Copyright © 2009 European Association of Urology Terms and Conditions

3. Fig. 2 Kaplan-Meier plot of recurrence-free survival.*
CI=confidence interval; GEM=gemcitabine; PBO=placebo; HR=hazard ratio.
* Noneligible patients were censored at baseline.
European Urology  , DOI: ( /j.eururo )
Copyright © 2009 European Association of Urology Terms and Conditions